Solid Biosciences Inc.SLDBNASDAQ
LOADING
|||
Cash Flow Under Pressure
Below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-100.67M
↓ 48% below average
Average (9y)
$-67.92M
Historical baseline
Range
High:$-4.20M
Low:$-100.99M
CAGR
+42.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-100.67M | -5.2% |
| 2023 | $-95.69M | +5.2% |
| 2022 | $-100.99M | -27.8% |
| 2021 | $-79.05M | -37.5% |
| 2020 | $-57.50M | +40.8% |
| 2019 | $-97.10M | -24.5% |
| 2018 | $-77.97M | -71.4% |
| 2017 | $-45.50M | -121.8% |
| 2016 | $-20.51M | -387.9% |
| 2015 | $-4.20M | - |